Steven E. Bowen

FDA investigator

Appears on 6 documents from 2019 to 2024, most often at sites in Israel. Most often cites design and construction features (21 CFR 211.42).

6
Documents on file
6.2
Observations per 483
2019
First seen
2024
Most recent

What they cite most

From 37 observations

Activity by year

2019: 1, 2020: 4, 2024: 1

Where

Israel 2 · Texas 2 · Japan 1 · North Carolina 1

Is Steven E. Bowen coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 OMRIX BIOPHARMACEUTICALS LTDFeb 24, 2024 · RAMAT GAN, Israel
483 Lonza Houston, Inc.Dec 10, 2020 · Houston, Texas
483 Lonza Houston, IncDec 10, 2020 · Houston, Texas
483 Omrix Biopharmaceuticals LtdMar 5, 2020 · Rehovot, Israel
483 Merck Teknika LLCJan 24, 2020 · Durham, North Carolina
483 TOYOBO CO., LTD.Jul 30, 2019 · Otsu, Japan

About this profile

What does Steven E. Bowen inspect?

Steven E. Bowen appears on 6 documents on file covering 5 sites, most often in Israel.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.100 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Steven E. Bowen is dated Feb 24, 2024.